333 Jackson Plaza
Ann Arbor, MI 48103
Leveraging cutting-edge technologies to enable early cancer detection and improvement of patient care
We are committed to sparing as many patients as possible from undergoing invasive and potentially harmful interventions to know if they have cancer. Our diagnostic tools empower patients and clinicians to confidently navigate the complex and important process of cancer detection.
WE ARE DOING OUR PART TO FIGHT COVID-19
LynxDx has focused our lab efforts on COVID-19 testing, particularly for our vulnerable and high-risk populations. Our goal is to increase testing within our community as our nation works towards mitigating the impact of this pandemic.
WE DEVELOP IMPACTFUL DIAGNOSTIC TOOLS
Our mission is to improve patient care through translation of cutting-edge technologies. In addition to using our vast scientific expertise to active develop novel diagnostic tools, we work to actually see these tools used in clinical practice.
MPS is a prostate cancer diagnostic assay that measures urine levels of cancer specific genes in the urine. By equipping clinicians with the ability to confidently rule out cases where biopsy is not needed, MPS can have significant impact both on patient wellness, sparing patients from invasive and morbid biopsies, and on the healthcare system at large, saving hundreds of millions of dollars that would have been spent on biopsies and their complications.